Literature DB >> 30683258

(At Least) Once in Her Lifetime: Global Cervical Cancer Prevention.

Philip E Castle1, Amanda Pierz2.   

Abstract

Cervical cancer disproportionately burdens lower-resourced settings, in which nearly 90% of cervical cancer and cervical cancer-related deaths occur. Targeting human papillomavirus (HPV) by prophylactic HPV vaccination in young adolescent girls and HPV-based screening in mid-adult women offers the most cost-effective strategy to reduce cervical cancer burden worldwide and mitigate the health disparities in cervical cancer burden between low-resourced and high-resourced settings. Political and social will, along with the necessary financial investments, will be necessary to realize the opportunity for significant global reductions in the cervical cancer burden. Perfect cervical cancer prevention (total eradication) is practically and financially unrealistic.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Cervical intraepithelial neoplasia (CIN); Cytology; Global health; Human papillomavirus (HPV); Pap; Screening; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 30683258     DOI: 10.1016/j.ogc.2018.09.007

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  1 in total

1.  Lysine Acetyltransferase 2B predicts favorable prognosis and functions as anti-oncogene in cervical carcinoma.

Authors:  Lei Li; Juntao Zhang; Shuping Cao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.